Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet

NCT05886933 · clinicaltrials.gov ↗

COMPLETED

Status

9846

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Fexuprazan Hydrochloride

Sponsor

Daewoong Pharmaceutical Co. LTD.